Alzheimer's

• Hundreds walk, run in support of Calgary families affected by dementia

  Hundreds of people laced up for the annual Alzheimer Calgary Walk and Run, raising money in support of Calgary-area families who are impacted by dementia.

  Health

  Oct 13
  
• FDA approves new Alzheimer’s drug that slows memory decline

  A key differentiating factor for donanemab is the drug's finite dosing, which allows patients to stop taking the treatment once brain scans no longer show amyloid plaques.

  Health

  Jul 3
  
• Advertisement
• Holding onto a memory: Why 2 Calgary seniors are taking a unique ride

  Mike and Bev Pannett mark World Bicycle Day with a ride on a trishaw bike. The couple are trying to make as many memories as they can as Bev battles Alzheimer's.

  Features

  Jun 3
• Advertisement
• Saskatchewan scientist fights brain disease with ‘mini-brains’

  Dr. Tyler Wenzel, a postdoctoral fellow at the University of Saskatchewan, is conducting research that could revolutionize the way we diagnose and treat diseases of the brain.

  Health

  Jun 2
• How ‘dementia village’ model could be spread to long-term care throughout B.C.

  Pilot projects are underway to bring a model of care inspired by European dementia villages to long-term care homes throughout British Columbia.

  Health

  May 22
• Daughter of missing senior calls for critical incident review, continues ground search

  "I just don't want to see this happen to anybody," said Britt Moberg.

  Health

  May 6
• Neurological conditions affect 3.4B people worldwide. What about Canada?

  Neurological conditions, such as Alzheimer's disease, migraines, stroke and multiple sclerosis, are now the leading of ill health and disability around the world.

  Health

  Mar 15
• National class action approved for users of this antipsychotic drug

  The companies behind a drug that was recently approved to treat symptoms of agitation in Alzheimer's patients are facing a class-action lawsuit over alleged 'harmful side effects.'

  Health

  Mar 14
• Advertisement
• Decision on Eli Lilly’s Alzheimer’s drug delayed by U.S. FDA

  The U.S. Food and Drug Administration has delayed its decision on Eli Lilly's LLY.N experimental treatment for early Alzheimer's disease.

  Health

  Mar 8
• Advertisement
• After weeks of silence, Victoria patient’s hospital room TV will be fixed

  Diane Moffatt has been at the Royal Jubilee Hospital since Dec. 27, receiving treatment for a urinary tract infection. She also lives with Alzheimer's disease. 

  Health

  Feb 20